Juvisync

Active Ingredient(s): Sitagliptin + Simvastatin
FDA Approved: * October 7, 2011
Pharm Company: * MERCK SHARP DOHME
Category: Diabetes

Sitagliptin/simvastatin, sold under the brand name Juvisync, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes and hypercholesterolemia. It contains sitagliptin and simvastatin. Sitagliptin is a dipeptidyl peptidase-4 inhibitor and simvastatin is an HMG-CoA reductase inhibitor.[1] These two disorders commonly occur in patients at the same time, and have been typically treated with administration of these two drugs in separate tablets. The com... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Juvisync 757
Juvisync 100/20 (Sitagliptin / Simvastatin) Oral Tablet
NDC: 0006-0757
Labeler:
Merck Sharp & Dohme Corp.
Juvisync 773
Juvisync 100/40 (Sitagliptin / Simvastatin) Oral Tablet
NDC: 0006-0773
Labeler:
Merck Sharp & Dohme Corp.
Juvisync 50/10 (Sitagliptin 50 mg (Sitagliptin Phosphate Monohydrate 64.25 mg) / Simvastatin 10 mg) Oral Tablet
NDC: 0006-0533
Labeler:
Merck Sharp & Dohme Corp.
Juvisync 50/20 Oral Tablet
NDC: 0006-0535
Labeler:
Merck Sharp & Dohme Corp.
Juvisync 50/40 Oral Tablet
NDC: 0006-0537
Labeler:
Merck Sharp & Dohme Corp.
Juvisync 100/10 (Sitagliptin / Simvastatin) Oral Tablet
NDC: 0006-0753
Labeler:
Merck Sharp & Dohme Corp.